5 November 2015
DETAILS
- EBITDA pre exceptionals for full year 2015 now
expected between EUR 860 million and EUR 900 million - EBITDA pre exceptionals in the third quarter 2015
improved by around 12 percent to EUR 235 million;
net income up 17 percent to EUR 41 million - Realignment of business being accelerated:
Additional annual savings of EUR 150 million
from the end of 2019 on to be achieved
by optimizing plant network - New strategic focus:
* Advanced Intermediates,
* Performance Chemicals and
* High Performance Materials
to serve as platform for future growth - EUR 60 million capital expenditure for Leverkusen site
CEO Matthias Zachert:
“LANXESS will become a more profitable and
less cyclical specialty chemicals company
with growth potential.”
CONTACT LANXESS
WWW.CHEMWINFO.COM BY KHUN PHICHAI